Invesco’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $181K | Buy |
155,714
+6,230
| +4% | +$7.23K | ﹤0.01% | 3536 |
|
|
2025
Q1 | $238K | Buy |
149,484
+98,612
| +194% | +$157K | ﹤0.01% | 3428 |
|
|
2024
Q4 | $154K | Sell |
50,872
-590
| -1% | -$1.79K | ﹤0.01% | 3545 |
|
|
2024
Q3 | $189K | Sell |
51,462
-2,347
| -4% | -$8.64K | ﹤0.01% | 3514 |
|
|
2024
Q2 | $220K | Sell |
53,809
-557
| -1% | -$2.28K | ﹤0.01% | 3581 |
|
|
2024
Q1 | $857K | Buy |
54,366
+29,416
| +118% | +$464K | ﹤0.01% | 3060 |
|
|
2023
Q4 | $378K | Sell |
24,950
-111,611
| -82% | -$1.69M | ﹤0.01% | 3346 |
|
|
2023
Q3 | $2.74M | Buy |
136,561
+6,281
| +5% | +$126K | ﹤0.01% | 2474 |
|
|
2023
Q2 | $3.68M | Buy |
130,280
+104,647
| +408% | +$2.95M | ﹤0.01% | 2390 |
|
|
2023
Q1 | $441K | Buy |
25,633
+575
| +2% | +$9.89K | ﹤0.01% | 3314 |
|
|
2022
Q4 | $505K | Sell |
25,058
-1,958
| -7% | -$39.4K | ﹤0.01% | 3240 |
|
|
2022
Q3 | $586K | Buy |
27,016
+3,391
| +14% | +$73.6K | ﹤0.01% | 3149 |
|
|
2022
Q2 | $664K | Sell |
23,625
-73,830
| -76% | -$2.08M | ﹤0.01% | 3173 |
|
|
2022
Q1 | $4.5M | Sell |
97,455
-121,660
| -56% | -$5.61M | ﹤0.01% | 2423 |
|
|
2021
Q4 | $18.4M | Buy |
219,115
+88,303
| +68% | +$7.42M | ﹤0.01% | 1618 |
|
|
2021
Q3 | $8.72M | Sell |
130,812
-14,437
| -10% | -$962K | ﹤0.01% | 2076 |
|
|
2021
Q2 | $7.73M | Sell |
145,249
-87,758
| -38% | -$4.67M | ﹤0.01% | 2211 |
|
|
2021
Q1 | $10.1M | Sell |
233,007
-43,062
| -16% | -$1.87M | ﹤0.01% | 1943 |
|
|
2020
Q4 | $14.3M | Buy |
276,069
+2,960
| +1% | +$154K | ﹤0.01% | 1615 |
|
|
2020
Q3 | $8.93M | Sell |
273,109
-4,284
| -2% | -$140K | ﹤0.01% | 1706 |
|
|
2020
Q2 | $13.3M | Buy |
+277,393
| New | +$13.3M | ﹤0.01% | 1478 |
|